HUDSON RCI IPN049200Recalls & reported problems
Teleflex Incorporated · ADDIPAK 0.9% NaCl for Inhalation USP, 5 mL · Class 2
All models of HUDSON RCI (152)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 14026704628145), received between Apr 23, 2021 and Dec 3, 2021 — classified as 1 malfunction.
The most frequently reported specific device problem is “Off-Label Use” (1 report).
1 other recall cover devices cleared under the same FDA submission (K142153); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Off-Label Use1
- Patient Device Interaction Problem1
Patient problems
- Burning Sensation1
- Eye Burn1
- Itching Sensation1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
Dec 3, 2021Off-Label Use
CONSUMER HAS BEEN USING ADDIPAK SINGLE USE 5 ML STERILE 0.9% NACL WITH THEIR SCLERAL HARD CONTACT LENSES, FOR A FEW YEARS WITHOUT ISSUE. THE CONSUMERS DOCTOR RECOMMENDED THE USE OF THIS PRODUCT IN AN OFF-LABEL MANNER. THE CONSUMER PURCHASED 2 NEW BOXES OF ADDIPAK IN LATE (B)(6) 2021 AND BEGAN USE OF THE NEW BOXES IN (B)(6) 2021. UPON THE FIRST USE OF THE ADDIPAK SALINE FROM THE NEW BOXES/LOT THE CONSUMER STATED THEY NOTED AN IMMEDIATE BURNING AND EYE IRRITANT, LIKE A CHEMICAL REACTION. COMPLAINT # (B)(4).
Patient problems: Burning Sensation; Eye Burn
MAUDE report 12933998 ↗MalfunctionApr 23, 2021Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED "ITEM CAUSED ITCHING AND BURNING". UNKNOWN IF PATIENT HAD PREVIOUS ALLERGIES. NO HARM OR INJURY REPORTED. PATIENT CONDITION REPORTED AS "FINE".
Patient problems: Itching Sensation
MAUDE report 11712725 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K142153. One submission often covers many models, so check the product and lot details in each record.
- Z-2514-2023 · Aug 4, 2023 · Open, ClassifiedHUDSON RCI Addipak, UNIT DOSE VIALS, 5mL Sterile 0.9% NaCl Solution for Inhalation USP. REF RHUD59U
Other NEBULIZER (DIRECT PATIENT INTERFACE) devices
- HUDSON RCI IPN049807Teleflex Incorporated · NEBULIZER (DIRECT PATIENT INTERFACE)62 reports
- Circulaire™ 0330Sunmed, LLC · Nebulizer (Direct Patient Interface)1 recall0 reports
- I neb 00Respironics Respiratory Drug Delivery (Uk) Ltd · NEBULIZER (DIRECT PATIENT INTERFACE)3 deaths15 reports
- VixOne 0209Westmed, Inc. · Nebulizer (Direct Patient Interface)13 reports
- HUDSON RCI IPN040620Teleflex Incorporated · NEBULIZER (DIRECT PATIENT INTERFACE)12 reports
- HUDSON RCI IPN049808Teleflex Incorporated · NEBULIZER (DIRECT PATIENT INTERFACE)6 reports
- HUDSON RCI HUD05014Medline Industries, Inc. · Nebulizer (direct patient interface)6 reports
- VixOne 0210Westmed, Inc. · Nebulizer (Direct Patient Interface)5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page